Today: 7 February 2026
Subscribe
Browse Category

Investments News 29 January 2026 - 30 January 2026

Eli Lilly stock barely budges after $1.93bn autoimmune pact; Trump touts six U.S. plants

Eli Lilly stock barely budges after $1.93bn autoimmune pact; Trump touts six U.S. plants

Eli Lilly shares closed up 0.03% at $1,024.14 after announcing new research deals in autoimmune disease and gene-editing for hearing loss. Repertoire Immune Medicines will receive $85 million upfront in a collaboration potentially worth $1.84 billion. Lilly also signed a gene-editing agreement with Seamless Therapeutics valued up to $1.12 billion. Investors await Feb. 4 earnings for updates on demand and supply.
30 January 2026
·····
Joby Aviation stock slides after $1.2 billion deal; dilution and hedging now in focus

Joby Aviation stock slides after $1.2 billion deal; dilution and hedging now in focus

Joby Aviation shares plunged 16.8% to $11.14 after the company announced a $1.2 billion stock and convertible note offering, including $600 million in 0.75% notes due 2032. The deal, upsized from $1 billion, will settle Feb. 2. Traders focused on the impact of new share supply and hedging activity tied to the convertible notes. Other eVTOL stocks also fell, but Joby’s drop was steeper.
30 January 2026
·····
Lockheed Martin stock jumps after Pentagon missile deal and upbeat 2026 forecast

Lockheed Martin stock jumps after Pentagon missile deal and upbeat 2026 forecast

Lockheed Martin shares jumped 4.1% to $622.51 in late trading Thursday after the company raised its 2026 outlook and announced a profit-sharing deal tied to higher missile production. The company reported quarterly earnings of $5.80 per share on $20.3 billion in sales and forecast 2026 revenue above Wall Street estimates. Lockheed cited record demand for air-defense systems and flagged policy uncertainty on shareholder payouts.
30 January 2026
····
CoreWeave stock price dips below $100 as insider sale filing hits CRWV after Nvidia-run rally

CoreWeave stock price dips below $100 as insider sale filing hits CRWV after Nvidia-run rally

CoreWeave shares fell 6.1% to $99.53 on Thursday, staying near that level after hours. An SEC filing showed Chief Development Officer Brannin McBee sold 33,335 shares under a pre-arranged plan. The stock had surged earlier in the week after Nvidia disclosed a $2 billion stake. Investors await CoreWeave’s earnings report in mid-February.
30 January 2026
·····
Robinhood puts money into Talos at a $1.5 billion valuation as crypto trading plumbing draws fresh backers

Robinhood puts money into Talos at a $1.5 billion valuation as crypto trading plumbing draws fresh backers

Robinhood joined a $45 million Series B extension for crypto trading tech firm Talos, raising Talos’s total Series B funding to $150 million and valuing the company at about $1.5 billion. Talos said stablecoins were used to settle part of the transaction. The firm reported nearly doubling revenue and client numbers annually for the past two years.
29 January 2026
·······
Meta stock jumps nearly 11% as Wall Street sizes up $135 billion AI spending plan

Meta stock jumps nearly 11% as Wall Street sizes up $135 billion AI spending plan

Meta shares jumped 10.7% after the company posted fourth-quarter revenue of $59.89 billion, up 24%, and issued a strong first-quarter outlook. The company forecast 2026 expenses of $162–169 billion and capital spending of $115–135 billion. Advertising revenue rose 24% to $58.14 billion. Meta warned of higher costs tied to data centers and AI, pressuring margins.
29 January 2026
·····
IBM stock rises after earnings beat, as Wall Street zeroes in on Red Hat and Washington risk

IBM stock rises after earnings beat, as Wall Street zeroes in on Red Hat and Washington risk

IBM shares rose 3.3% to $304.01 Thursday after reporting fourth-quarter revenue of $19.7 billion and adjusted earnings of $4.52 per share, beating forecasts. The gain contrasted with declines in other software stocks as investors questioned AI investment returns. Red Hat growth slowed to 10%, partly due to a U.S. government shutdown. IBM will stop reporting its “AI book of business” separately starting next quarter.
29 January 2026
·····
Meta stock jumps nearly 10% after earnings, even with $135 billion AI spending plan

Meta stock jumps nearly 10% after earnings, even with $135 billion AI spending plan

Meta shares surged 10% to $735.36 Thursday after reporting a 24% jump in Q4 revenue to $59.89 billion, fueled by strong ad sales. The company forecast 2026 capital expenditures of $115–$135 billion, far above 2025 levels, to support AI expansion. Investors weighed the results against rising costs and legal risks. Meta also warned of regulatory challenges in its SEC filing.
29 January 2026
·····
Eli Lilly stock price today: LLY rises on $1.93 billion Repertoire deal as earnings near

Eli Lilly stock price today: LLY rises on $1.93 billion Repertoire deal as earnings near

Eli Lilly shares rose 0.5% Thursday after Repertoire Immune Medicines announced a partnership with the company worth up to $1.93 billion. The deal follows Lilly’s $1.12 billion gene-editing agreement targeting hearing loss. Investors are also watching for Medicare’s plan to include Trulicity in upcoming price negotiations. Lilly’s earnings report is expected Feb. 4.
29 January 2026
······
1 … 8 9 10 11 12 … 82

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop